Medical devices, healthcare technology and the business of care
PMA approval · P250015

PerQseal Elite Vascular Closure Device

Vivasure Medical , Ltd. · Decision date Oct 16, 2026

FDA DECISIONP250015

What did the FDA approve?

FDA records P250015 as an original PMA application. The recorded decision is approval, dated Oct 16, 2026.

FDA approval order statement

Approval for the PerQSeal Elite Vascular Closure Device. The device is indicated for the percutaneous closure of common femoral arteriotomies in patients following interventional endovascular catheterization procedures utilizing 14 22 F sheaths (arteriotomies up to 26 F).
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Oct 16, 2026

FDA source record

Regulatory record facts

Identifier
P250015
Regulatory pathway
Premarket approval application
Product code
MGB
Decision code
APPR
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, hemostasis, vascular.

Product code
MGB
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P250015 received

    Application receipt date recorded by FDA.

  2. P250015 · FDA decision

    APPR

Timeline entries are records held by MedtechLedger for P250015. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

Other records with product code MGB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Vivasure Medical , Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Parkmore Business Park W., Galway, H91 V3KP

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records